Medicare Part D: Good for Patients and an Opportunity for Pharmacists

Joshua S. Benner and
Joshua S. Benner Former Brookings Expert, President and CEO - RxAnte
S. Lawrence Kocot
S. Lawrence Kocot Former Brookings Expert, Principal and National Leader, Center for Healthcare Regulatory Insight - KPMG

February 2, 2009


With more than 25 million Medicare beneficiaries enjoying guaranteed access and choice of a drug benefit in 2008, and 2009 average monthly plan premiums projected at a 37% lower cost than 2003 estimates, it’s safe to say the Medicare Part D prescription drug benefit continues to prove it’s worth.  Part D isn’t just beneficial to Medicare beneficiaries, however; pharmacists play an increasingly important role in delivering this benefit, and must recognize the opportunity for sizeable economic growth. Josh Benner and Larry Kocot explore this issue in their editorial, “Medicare Part D: Good for Patients and an Opportunity for Pharmacists.”

Read the full article in the Journal of Managed Care Pharmacy »